Does OSIMERTINIB Cause Small cell lung cancer? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Small cell lung cancer have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.2% of all adverse event reports for OSIMERTINIB.
46
Reports of Small cell lung cancer with OSIMERTINIB
0.2%
of all OSIMERTINIB reports
11
Deaths
3
Hospitalizations
How Dangerous Is Small cell lung cancer From OSIMERTINIB?
Of the 46 reports, 11 (23.9%) resulted in death, 3 (6.5%) required hospitalization, and 1 (2.2%) were considered life-threatening.
Is Small cell lung cancer Listed in the Official Label?
Yes, Small cell lung cancer is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Small cell lung cancer?
CARBOPLATIN (74)
TARLATAMAB-DLLE (66)
ETOPOSIDE (65)
ATEZOLIZUMAB (62)
METHOTREXATE (35)
AFATINIB (30)
ADALIMUMAB (29)
GEFITINIB (28)
NINTEDANIB (28)
TACROLIMUS (28)
Which OSIMERTINIB Alternatives Have Lower Small cell lung cancer Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN